FILLDERM Trademark

Trademark Overview


On Tuesday, April 12, 2022, a trademark application was filed for FILLDERM with the United States Patent and Trademark Office. The USPTO has given the FILLDERM trademark a serial number of 79341039. The federal status of this trademark filing is REGISTERED as of Tuesday, October 31, 2023. This trademark is owned by DATAZI PHARMA LTD. The FILLDERM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in dermatology; injectable preparations for medical and pharmaceutical purposes, namely, injectable dermal fillers; pharmaceutical preparations made from hyaluronic acid for use in dermatology; pharmaceutical preparations made from lidocaine for use in dermatology; injectable preparations made from lidocaine for use as local anesthetics; injectable preparations made from hyaluronic acid for use in dermatology; filled syringes sold filled with pharmaceutical preparations made from lidocaine and hyaluronic acid for medical purposes; pre-filled syringes sold filled with pharmaceutical preparations made from lidocaine and hyaluronic acid for medical purposes
fillderm

General Information


Serial Number79341039
Word MarkFILLDERM
Filing DateTuesday, April 12, 2022
Status700 - REGISTERED
Status DateTuesday, October 31, 2023
Registration Number7203922
Registration DateTuesday, October 31, 2023
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 15, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized wording "FILLDERM" to the right of a circular design comprised of smaller circles and asymmetrical cell shapes, all in teal.
Goods and ServicesPharmaceutical preparations for use in dermatology; injectable preparations for medical and pharmaceutical purposes, namely, injectable dermal fillers; pharmaceutical preparations made from hyaluronic acid for use in dermatology; pharmaceutical preparations made from lidocaine for use in dermatology; injectable preparations made from lidocaine for use as local anesthetics; injectable preparations made from hyaluronic acid for use in dermatology; filled syringes sold filled with pharmaceutical preparations made from lidocaine and hyaluronic acid for medical purposes; pre-filled syringes sold filled with pharmaceutical preparations made from lidocaine and hyaluronic acid for medical purposes
Indication of Colors claimedThe color(s) teal is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDATAZI PHARMA LTD
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressCY

Party NameDATAZI PHARMA LTD
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCY

Party NameDATAZI PHARMA LTD
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCY

Party NameDATAZI PHARMA LTD
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressCY

Party NameDATAZI PHARMA LTD
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCY

Trademark Events


Event DateEvent Description
Thursday, May 19, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Monday, May 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 27, 2022APPLICATION FILING RECEIPT MAILED
Monday, January 30, 2023ASSIGNED TO EXAMINER
Tuesday, January 31, 2023NON-FINAL ACTION WRITTEN
Wednesday, February 1, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 28, 2023REFUSAL PROCESSED BY MPU
Tuesday, March 28, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, April 19, 2023REFUSAL PROCESSED BY IB
Friday, June 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 2, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 2, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, August 15, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 15, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sunday, August 20, 2023NOTIFICATION PROCESSED BY IB
Wednesday, October 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, October 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 31, 2023REGISTERED-PRINCIPAL REGISTER
Sunday, November 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, January 31, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, February 2, 2024FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 2, 2024FINAL DISPOSITION PROCESSED
Monday, February 26, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 9, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB